- Report this article
Téa Romero, MPsy, MBA
Téa Romero, MPsy, MBA
Director Alliance Management| Relationship Manager | Community Creator |Client Success | Founder | Board Member | Moderator | ERGs Lead | Researcher | People Manager | Writer | Photographer | Rainy Weather Enthusiast
Published Jan 2, 2024
+ Follow
As we start 2024, our post-pandemic culture is well versed as to why clinical trials play a crucial role in advancing medical research and improving healthcare outcomes. We experienced firsthand the best of the research industry, the ability to quickly build on and expand the mRNA research we had at hand, and the community outreach and education to save lives through FDA's emergency use authorization (EUA) for vaccines and antiviral medications.
During the pandemic and now post-pandemic, the question I often received from family and friends seems simple; what do you call someone taking a study drug? Each reporter and article seemed to use different terminology, and the inconsistent use of patient, subject, volunteer or participant in clinical trials can be confusing, especially to those outside the industry.
To clarify the terms patients, subjects, volunteers, or participants all refer to the heroes among us who selflessly participate in clinical research to advance medicine. These heroes rarely get the recognition they deserve. Volunteering to participate in research is pivotal to medicine, technology, and medical device innovations.
Now, let’s explore the common terms to use and why it matters.
1. Patients: Patient is used to refer to individuals receiving medical care. In the context of clinical trials, this term is most appropriate starting at Phase II trials and beyond, trials which involve individuals with a specific medical condition or disease. Referring to the volunteers as patients acknowledges their existing health status and the fact that they are seeking treatment through clinical research.
2. Subjects: Subjects, while widely used in the past to refer to individuals participating in clinical trials, this term has gradually fallen out of favor due to its passive connotation. It implies that individuals are merely a number, making up the subset or population sample, devoid of their humanness, agency or active involvement.
3. Volunteers: This term applies to individuals who willingly and without coercion choose to participate in a clinical trial. Using the term, volunteer, highlights the selflessness and altruism of those individuals who offer their time, effort, and even their bodies for the advancement of medical research. It is important for us to remember that ALL medication comes with risk, even an over-the-counter medication as commonly used as ibuprofen has side effects and cannot be used by all people.
Recommended by LinkedIn
Using the term volunteer emphasizes their active decision to participate, contribute to scientific knowledge, and potentially help others in the future.
4. Participants: Participant is the term increasingly preferred in the field of clinical research and most often read in medical protocols. It recognizes the active role individuals play in clinical trials. By referring to them as participants, we acknowledge their voluntary involvement, active engagement, and contribution to the research process. This term emphasizes the partnership between researchers and individuals, promoting a sense of empowerment and collaboration.
Why terminology matters:
As we look to increase diversification in clinical trials the choice of terminology reflects our evolving understanding of the role individuals play in clinical trials. Using the appropriate term is not just a matter of semantics; it can shape the perception of volunteers and influence their sense of involvement in the research process.
By using the terms such as volunteer or participants, we foster a positive and respectful relationship between researchers and individuals involved in clinical trials without specifying if the individual requires medical treatment. It acknowledges their autonomy, decision-making capacity, and willingness to contribute to medical progress. This seemingly small inclusive approach can lead to increased trust, better recruitment rates, and improved retention in clinical trials.
While "patients" is appropriate when referring to individuals with a medical condition and/or seeking medical treatment, the terms “volunteers” & "participants" don't specify medical need and are increasingly preferred due to the recognition of their active involvement and agency. This shift in language reflects a more #inclusive and #collaborative approach, fostering a positive research environment.
Let's embrace the power of words to ensure the everyday heroes in clinical research feel valued, respected, and empowered on their journey towards advancing medical knowledge.
Like
Celebrate
Support
Love
Insightful
Funny
62
17 Comments
Dr. Rajgopal Yadavalli, Ph.D
Research Scientist in Biomedical Research with Experience in Medical/Scientific Writing (Publications)/Medical Communications/Medical Affairs
2mo
- Report this comment
We still see many clinical studies published and appearing in PUBMED with "subjects" used in the study titles. We need to strike a consensus in this regard with use of these varying terms such as "subjects", "participants" and so on, and should be made clear with a clarion call in the ICH-GCP guidelines as a mandatory step.
1Reaction 2Reactions
Yogita Kolekar Thoke🌟
✨Global Biostatistician | Reimagining Medicine to Improve and Extend Lives| Clinical Trials | Analyzing Health Data for Evidence-Based Insights and Public Health Impact🚀|LinkedIn Top Voice
7mo
- Report this comment
Great insights Téa Romero, MPsy, MBA.
1Reaction
Sherri Phillips
What sets you apart from your competition? YOU! Why blend in when you were born to stand out?
8mo
- Report this comment
I appreciate that distinction between patients and volunteers/participants, Téa Romero, MPsy, MBA. Language really does matter.
1Reaction 2Reactions
Paul Kirch
I provide empowering resources to help business leaders and executives thrive during any economic condition, leading to strategic growth. Through proven marketing strategies and my empowering Think Tank Community.
8mo
- Report this comment
A great read, Téa Romero, MPsy, MBA
2Reactions 3Reactions
Tina Larsson
I help NYC co-op & condo owners increase their property value💲| Coop & Condo Board Consultant | Make buildings safer, more sustainable & more affordable | Podcast Guest | Published SPEAKer | Strategy Session BELOW 👇🏻
8mo
- Report this comment
Great insights, Téa Romero, MPsy, MBA! As someone from a different industry, your article helped me understand the importance of language in clinical trials. Keep up the good work!
2Reactions 3Reactions
See more comments
To view or add a comment, sign in
More articles by Téa Romero, MPsy, MBA
-
The Research Mixer: August Op-Ed
Aug 28, 2024
The Research Mixer: August Op-Ed
The Case for Compensating Clinical Trial Participants: A Win-Win for Patients & Scientific Progress In the realm of…
20
1 Comment
-
The Research Mixer: Inside Insights June/July 2024
Jul 25, 2024
The Research Mixer: Inside Insights June/July 2024
Clinical Research Mixer’s Curated Research Highlights Caring beyond Prescriptions: The biotech industry made headlines…
28
2 Comments
-
Clinical Research Mixer’s Curated Research Highlights May 2024
May 29, 2024
Clinical Research Mixer’s Curated Research Highlights May 2024
May 2024 Clinical Research Mixer’s Curated Research Highlights Caring beyond Prescriptions: Regeneron hosts the world’s…
12
-
April 15- April 19 Clinical Research Mixer’s Curated Research News Highlights
Apr 18, 2024
April 15- April 19 Clinical Research Mixer’s Curated Research News Highlights
Caring beyond Prescriptions: Aflac Duck ! known as the My Special Aflac Duck® is a cuddly soft companion for children…
26
3 Comments
-
The Dynamics of Partnerships in Clinical Research: Trends and Insights for 2024
Apr 12, 2024
The Dynamics of Partnerships in Clinical Research: Trends and Insights for 2024
In today's rapidly evolving landscape of clinical development, strategic partnerships have emerged as a driving force…
23
2 Comments
-
Competition to Collaboration: A Path to Success
Mar 21, 2024
Competition to Collaboration: A Path to Success
In the fast-paced corporate world, the mindset of scarcity is often centralized, and competition is promoted as a…
3
-
Storytelling: A Tool of Resilience in the Professional World
Mar 12, 2024
Storytelling: A Tool of Resilience in the Professional World
In the tapestry of the professional world, the threads woven by women are often undervalued and underestimated. In a…
24
5 Comments
-
Finding Balance: Avoiding Burnout as a Woman in Leadership
Mar 7, 2024
Finding Balance: Avoiding Burnout as a Woman in Leadership
Women’s History Month is a significant time to honor and recognize the remarkable contributions of women throughout…
17
5 Comments
-
Feb 28, 2024
cultivating & nurturing collaborative networks
Nature serves as an unending well of inspiration and wisdom for us humans. Recently, during a birdwatching session, I…
15
5 Comments
-
Orphan Drug Act's Impact on Rare Disease Patients
Feb 21, 2024
Orphan Drug Act's Impact on Rare Disease Patients
Rare diseases, though individually uncommon, collectively affect a significant portion of the population worldwide…
16
3 Comments
See all articles
Sign in
Stay updated on your professional world
Sign in
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Insights from the community
- Medical Sales What are the best ways to conduct clinical trials for medical technology?
- Biotechnology How can you integrate patient perspectives into your clinical trial grant proposal?
- Bioengineering Struggling to incorporate clinical trial teams' feedback into your bioengineering prototypes?
- Laboratory Management What are the key metrics for tracking laboratory turnaround time?
- Statistics Here's how you can enhance clinical trial efficiency and effectiveness through statistical innovation.
- Experimental Design How do you compare and contrast split-plot designs with other experimental designs in healthcare research?
- Patient Advocacy What are the best practices for patient advocates to improve clinical trial outcomes?
- Laboratory Management What are the best practices for designing clinical trial experiments?
- Medical Sales What are the most common misconceptions about clinical studies?
- Research Management What does a clinical research coordinator do?
Others also viewed
- Why participant recruitment remains the biggest challenge in clinical trials MAC Clinical Research 2mo
- Enhancing Patient Retention in Clinical Trials: Proven Strategies for Success Manolo Ernesto Beelke 1w
- The Human Element in Clinical Trials: Driving Hope for a Better Future Jeff P. 1y
- 25+ useful clinical trial recruitment statistics for better results Antidote Technologies 11mo
- Clinical Trial Sites Reflecting Their Communities: The Importance of Clinical Trial Diversity and Community Alignment in Site Acquisitions Mark I. Weinberger, PhD, MPH 1y
- 25+ clinical trial recruitment statistics to inform your outreach strategy Antidote Technologies 1y
- What is patient centricity in clinical trials? Antidote Technologies 10mo
- Understanding Clinical Trial Results: How to Interpret Findings andWhat They Mean for Patients ParadigmIT 1y
- Top 5 Insights from Dan Sfera on Standard of Care in Clinical Trials Maya Zlatanova 3w
- CNS Rating Scales: Precision and Reliability in Clinical Trials Sofpromed Clinical Research, LLC 3mo
Explore topics
- Sales
- Marketing
- IT Services
- Business Administration
- HR Management
- Engineering
- Soft Skills
- See All